


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 8 Jun 2020
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
HSMN NewsFeed - 4 Jun 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
HSMN NewsFeed - 1 Jun 2020
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
HSMN NewsFeed - 1 Jun 2020
SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer
SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer
HSMN NewsFeed - 1 Jun 2020
Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans
Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans
HSMN NewsFeed - 29 May 2020
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
HSMN NewsFeed - 29 May 2020
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Acquist Therapeutics Announces New Appointments to its Board of Directors
HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
HSMN NewsFeed - 26 May 2020
Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
Relmada Therapeutics Appoints Molly Harper as Executive Vice President of Operations
HSMN NewsFeed - 26 May 2020
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
HSMN NewsFeed - 19 May 2020
BioEclipse Therapeutics(TM) Announces Move to New Corporate Headquarters in Mountain View, CA
BioEclipse Therapeutics(TM) Announces Move to New Corporate Headquarters in Mountain View, CA
HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
HSMN NewsFeed - 18 May 2020
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
HSMN NewsFeed - 13 May 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
HSMN NewsFeed - 8 May 2020
BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals
BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals
HSMN NewsFeed - 7 May 2020
FogPharma Appoints Tony Gibney as Chief Financial Officer and Chief Business Officer
FogPharma Appoints Tony Gibney as Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 7 May 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
HSMN NewsFeed - 4 May 2020
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 30 Apr 2020
Alpha Cognition, Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer's Therapy
Alpha Cognition, Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer's Therapy
HSMN NewsFeed - 30 Apr 2020
AcelRx Announces DSUVIA(R) Milestone C Approval and Provides Business Update
AcelRx Announces DSUVIA(R) Milestone C Approval and Provides Business Update
HSMN NewsFeed - 24 Apr 2020
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
HSMN NewsFeed - 22 Apr 2020
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
HSMN NewsFeed - 20 Apr 2020
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
Moleculin Announces Agreement with ImQuest Biosciences to Expand Coronavirus Testing
HSMN NewsFeed - 20 Apr 2020
Amblyotech, A Digital Therapeutics Company, Announces It Has Been Acquired by Novartis
Amblyotech, A Digital Therapeutics Company, Announces It Has Been Acquired by Novartis
HSMN NewsFeed - 20 Apr 2020
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations
HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
